Initial pharmacological therapies for newly diagnosed, drugs naïve patients with type 2 diabetes
Not Applicable
- Conditions
- T2DM
- Registration Number
- JPRN-UMIN000006860
- Lead Sponsor
- Biomedical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
hepatic/renal/cardiac/hypertensive disorder pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1, FBG,
- Secondary Outcome Measures
Name Time Method indexes for beta-cell function and insulin sensitivity, lipid parameters, body weight, blood pressure,